These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 16413939)

  • 1. Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions.
    Truong L; Allbutt H; Kassiou M; Henderson JM
    Behav Brain Res; 2006 Apr; 169(1):1-9. PubMed ID: 16413939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.
    Howells FM; Russell VA; Mabandla MV; Kellaway LA
    Behav Brain Res; 2005 Dec; 165(2):210-20. PubMed ID: 16159673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pallidotomy on motor symptoms in an animal model of Parkinson's disease.
    Henderson J; Doherty K; Allbutt H; Billing R
    Behav Brain Res; 2006 Apr; 169(1):29-38. PubMed ID: 16406102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wang T
    Brain Res; 2010 Apr; 1324():54-63. PubMed ID: 20149784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.
    Truong L; Allbutt HN; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):91-6. PubMed ID: 19007866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease.
    Blandini F; Armentero MT; Fancellu R; Blaugrund E; Nappi G
    Exp Neurol; 2004 Jun; 187(2):455-9. PubMed ID: 15144871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.
    Deumens R; Blokland A; Prickaerts J
    Exp Neurol; 2002 Jun; 175(2):303-17. PubMed ID: 12061862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
    Warraich ST; Allbutt HN; Billing R; Radford J; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):85-90. PubMed ID: 18822357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
    Iancu R; Mohapel P; Brundin P; Paul G
    Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.
    Kondoh T; Bannai M; Nishino H; Torii K
    Exp Neurol; 2005 Mar; 192(1):194-202. PubMed ID: 15698634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal dopaminergic fiber recovery after acute L-DOPA treatment in 6-hydroxydopamine (6-OHDA) lesioned rats.
    Fang C; Yin J; Xu Z; Wang Y; Xu H; Zhou H; Gao C
    Cell Biochem Biophys; 2011 Jan; 59(1):49-56. PubMed ID: 20714825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graded 6-OHDA-induced dopamine depletion in the nigrostriatal pathway evokes progressive pathological neuronal activities in the subthalamic nucleus of a hemi-parkinsonian mouse.
    Park SE; Song KI; Kim H; Chung S; Youn I
    Behav Brain Res; 2018 May; 344():42-47. PubMed ID: 29452192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.
    Moore AE; Cicchetti F; Hennen J; Isacson O
    Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys.
    Henderson JM; Stanic D; Tomas D; Patch J; Horne MK; Bourke D; Finkelstein DI
    Behav Brain Res; 2005 May; 160(2):267-76. PubMed ID: 15863223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration.
    Ghorayeb I; Puschban Z; Fernagut PO; Scherfler C; Rouland R; Wenning GK; Tison F
    Exp Neurol; 2001 Jan; 167(1):133-47. PubMed ID: 11161601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.